Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Objectives of study: To preliminarily evaluate the efficacy and safety of Qideng Mingmu
Capsule in the treatment of patients with diabetic retinopathy (deficiency of Qi-Yin
syndrome, blood stasis syndrome), to discuss the appropriate dose and period of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Chengdu University of Traditional Chinese Medicine
Collaborator:
Chongqing Taiji Group of Fuling pharmaceutical Co., LTD